hrcak mascot   Srce   HID

Stručni rad

Imipenem Consumption and Gram-Negative Pathogen Resistance to Imipenem at Sestre Milosrdnice University Hospital

Ines Benčić
Ivan Benčić
Dina Vukičević-Baudoin

Puni tekst: engleski, pdf (94 KB) str. 185-189 preuzimanja: 473* citiraj
APA 6th Edition
Benčić, I., Benčić, I. i Vukičević-Baudoin, D. (2001). Imipenem Consumption and Gram-Negative Pathogen Resistance to Imipenem at Sestre Milosrdnice University Hospital. Acta clinica Croatica, 40 (3), 185-189. Preuzeto s https://hrcak.srce.hr/14867
MLA 8th Edition
Benčić, Ines, et al. "Imipenem Consumption and Gram-Negative Pathogen Resistance to Imipenem at Sestre Milosrdnice University Hospital." Acta clinica Croatica, vol. 40, br. 3, 2001, str. 185-189. https://hrcak.srce.hr/14867. Citirano 18.11.2019.
Chicago 17th Edition
Benčić, Ines, Ivan Benčić i Dina Vukičević-Baudoin. "Imipenem Consumption and Gram-Negative Pathogen Resistance to Imipenem at Sestre Milosrdnice University Hospital." Acta clinica Croatica 40, br. 3 (2001): 185-189. https://hrcak.srce.hr/14867
Harvard
Benčić, I., Benčić, I., i Vukičević-Baudoin, D. (2001). 'Imipenem Consumption and Gram-Negative Pathogen Resistance to Imipenem at Sestre Milosrdnice University Hospital', Acta clinica Croatica, 40(3), str. 185-189. Preuzeto s: https://hrcak.srce.hr/14867 (Datum pristupa: 18.11.2019.)
Vancouver
Benčić I, Benčić I, Vukičević-Baudoin D. Imipenem Consumption and Gram-Negative Pathogen Resistance to Imipenem at Sestre Milosrdnice University Hospital. Acta clinica Croatica [Internet]. 2001 [pristupljeno 18.11.2019.];40(3):185-189. Dostupno na: https://hrcak.srce.hr/14867
IEEE
I. Benčić, I. Benčić i D. Vukičević-Baudoin, "Imipenem Consumption and Gram-Negative Pathogen Resistance to Imipenem at Sestre Milosrdnice University Hospital", Acta clinica Croatica, vol.40, br. 3, str. 185-189, 2001. [Online]. Dostupno na: https://hrcak.srce.hr/14867. [Citirano: 18.11.2019.]

Sažetak
The study was performed to determine the consumption of imipenem and resistance of gram-negative pathogens (Pseudomonas aeruginosa, Acinetobacter sp., Klebsiella sp., Escherichia coli, Proteus mirabilis, Serratia marcescens, Enterobacter sp.) to imipenem. Gram-negative pathogens were isolated at the Sestre milosrdnice University Hospital from Zagreb in 1999 and 2000. The imipenem sensitivity testing was performed by disk diffusion and E-test methods. The consumption of imipenem was expressed in DDD/100 hospital days in the same periods. Imipenem resistance of Acinetobacter sp. decreased significantly in the year 2000 (p=0.0052), especially in the first six months (p=0.021) when the lowest consumption of imipenem was recorded. Imipenem resistance of other gram-negative pathogens did not decrease significantly. Results suggest that the consumption of imipenem might lead to changes in resistance to imipenem among Acinetobacter strains.

Ključne riječi
Gram-negative bacterial infections; Cross infections; Drug resistance; Imipenem, therapeutic use; Imipenem, pharmacology

Hrčak ID: 14867

URI
https://hrcak.srce.hr/14867

[hrvatski]

Posjeta: 926 *